Skip to main content
. Author manuscript; available in PMC: 2008 Mar 29.
Published in final edited form as: Carcinogenesis. 2005 Nov 9;27(4):811–819. doi: 10.1093/carcin/bgi265

Fig. 2.

Fig. 2

SFN increases acetylated histone levels in prostate cell lines. Cells were treated with SFN or TSA as described in the legend to Figure 1, and acetylated histone H3 or acetylated histone H4 levels were assessed by immunoblotting. Equal protein loading was confirmed using β-actin. Results are representative of two or more separate experiments. Fold change was calculated using density values normalized to β-actin and expressed as relative change between SFN/TSA treated and control.